Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference
SEATTLE, Sept. 7, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific time in the Starlight North room of the Waldorf-Astoria Hotel.
The presentation with slides will be webcast live and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.
Annual Rodman & Renshaw Global Investment Conference
CTI presentation: Tuesday, September 11, 2012
10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific
Starlight North, Waldorf-Astoria Hotel
|
Media contact: |
Investors contact: |
|
Cell Therapeutics, Inc. |
Cell Therapeutics, Inc. |
|
Dan Eramian |
Ed Bell |
|
T: 206.272.4343 |
T: 206.272.4345 |
|
F: 206.272.4434 |
|
SOURCE Cell Therapeutics, Inc.
RELATED LINKS
http://www.celltherapeutics.com
More by this Source
Gemeinsamer Bundesausschuss (G-BA) gibt Beschluss über die Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a SGB V für Pixantron (Pixuvri®) bekannt.
May 21, 2013, 01:30 ET
German Federal Joint Committee (G-BA) Issues Final Assessment Report for PIXUVRI® (pixantrone)
May 20, 2013, 01:30 ET
Cell Therapeutics to Present at Upcoming Investor Conferences
May 15, 2013, 01:30 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
- Site Preview
-
Close Site Preview
-
View FullScreen
